An adjustment for a post-randomization variable in the comparison of two treatments for survival

Statistics in Medicine

Volumn 20, Issue 22, 2001, Pages 3475-3485

  Heller, Glenn ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK; STATISTICAL ANALYSIS; STATISTICAL MODEL; TREATMENT OUTCOME;

ANTIBIOTICS, ANTINEOPLASTIC; DAUNORUBICIN; HUMANS; IDARUBICIN; LEUKEMIA, MYELOCYTIC, ACUTE; LIKELIHOOD FUNCTIONS; MODELS, BIOLOGICAL; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS;

EID: 0035976617     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.968     Document Type: Article

References (13)

1. Regression models and life-tables
2. Properties of proportional-hazards score tests under misspecified regression models
3. Omitting covariates from the proportional hazards model
4. Compliance as an explanatory variable in clinical trials
5. Information bounds for the conditional hazard ratio in a nested family of regression models
6. Generalized profile likelihood and conditionally parametric models
7. On information and ancillarity in the presence of a nuisance parameter
8. Parameter orthogonality and approximate conditional inference
9. Generalized additive models
10. Results of a randomized trial comparing Idarubicin and Cytosine Arabinoside with Daunorubicin and Cytosine Arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
11. Weighted Kaplan-Meier statistics: A class of distance tests for censored survival data